When should potentially false research findings be considered acceptable?

scientific article

When should potentially false research findings be considered acceptable? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PMED.0040026
P3181OpenCitations bibliographic resource ID1751503
P932PMC publication ID1808081
P698PubMed publication ID17326703
P5875ResearchGate publication ID6479279

P50authorIztok HozoQ57085272
Benjamin DjulbegovicQ28050789
P2860cites workAt what degree of belief in a research hypothesis is a trial in humans justified?Q51040935
Acceptable regret in medical decision makingQ51084374
Regret graphs, diagnostic uncertainty and Youden's IndexQ51113974
Linking evidence-based medicine therapeutic summary measures to clinical decision analysisQ52083135
Equation and nomogram for calculation of testing and treatment thresholdsQ52307365
When (not) to stop a clinical trial for benefit.Q55041376
Equipoise, knowledge and ethics in clinical research and practiceQ58673192
Clinical trials as diagnostic tests.Q64993019
Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagusQ68122887
Why most published research findings are falseQ21092395
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 TrialQ21144715
Le Comportement de l'Homme Rationnel devant le Risque: Critique des Postulats et Axiomes de l'Ecole AmericaineQ29038489
Assessing the probability that a positive report is false: an approach for molecular epidemiology studiesQ29616285
Contradicted and initially stronger effects in highly cited clinical researchQ29620013
A proposed charter for clinical trial data monitoring committees: helping them to do their job wellQ33212101
Presumed benefit: lessons from the American experience with marrow transplantation for breast cancerQ33810287
Toward evidence-based medical statistics. 2: The Bayes factorQ33866194
Toward evidence-based medical statistics. 1: The P value fallacyQ33866199
Better reporting of harms in randomized trials: an extension of the CONSORT statementQ33983100
Therapeutic Decision Making: A Cost-Benefit AnalysisQ34082635
Null results in clinical trials: the need for a decision-theory approachQ36043832
Are all significant P values created equal? The analogy between diagnostic tests and clinical researchQ41456025
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)e26
P577publication date2007-02-01
P1433published inPLOS MEDICINEQ1686921
P1476titleWhen should potentially false research findings be considered acceptable?
P478volume4

Reverse relations

cites work (P2860)
Q33693923A regret theory approach to decision curve analysis: a novel method for eliciting decision makers' preferences and decision-making
Q36086675Assessing Institutional Ethics Committees in India Using the IRB-RAT.
Q39020380Computational Search for Possible Mechanisms of 4-Thiazolidinones Anticancer Activity: The Power of Visualization
Q40337089Determining optimal threshold for statins prescribing: individualization of statins treatment for primary prevention of cardiovascular disease
Q34401953Dual processing model of medical decision-making
Q30375899Epistemologic inquiries in evidence-based medicine.
Q37979709Evidence-based guideline of the German Nutrition Society: carbohydrate intake and prevention of nutrition-related diseases
Q97562240Evidence-based medicine in times of crisis
Q34111407Extensions to regret-based decision curve analysis: an application to hospice referral for terminal patients
Q38562652Insights from a Personal Journey in field of Orthopaedic Research and Publications
Q80733897Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer?
Q37329334Interpretation of tests of heterogeneity and bias in meta-analysis
Q29032830Meta-assessment of bias in science
Q37247261Pharmaco-epistemology for the prescribing geriatrician
Q42800368Stopping guidelines for an effectiveness trial: what should the protocol specify?
Q38630683Talking the talk, but not walking the walk: RT-qPCR as a paradigm for the lack of reproducibility in molecular research
Q34178142The False-positive to False-negative Ratio in Epidemiologic Studies
Q37641067The use of older studies in meta-analyses of medical interventions: a survey.
Q50752516Towards theory integration: Threshold model as a link between signal detection theory, fast-and-frugal trees and evidence accumulation theory
Q35242940Uncertainty and Equipoise: At Interplay Between Epistemology, Decision Making and Ethics
Q34778608When is diagnostic testing inappropriate or irrational? Acceptable regret approach
Q38353140When is rational to order a diagnostic test, or prescribe treatment: the threshold model as an explanation of practice variation
Q47843414When to perform hepatic resection for intermediate-stage hepatocellular carcinoma
Q34089254Why the need for qPCR publication guidelines?--The case for MIQE.

Search more.